Northern Trust Corp increased its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,352,046 shares of the health services provider's stock after buying an additional 153,992 shares during the period. Northern Trust Corp owned about 1.04% of Select Medical worth $25,486,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of SEM. LPL Financial LLC lifted its stake in shares of Select Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock worth $593,000 after purchasing an additional 619 shares during the period. Bank of Montreal Can lifted its position in Select Medical by 4.5% during the fourth quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider's stock worth $378,000 after buying an additional 867 shares during the period. Sippican Capital Advisors boosted its stake in Select Medical by 7.3% in the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock worth $252,000 after buying an additional 912 shares during the last quarter. Sterling Capital Management LLC grew its holdings in Select Medical by 9.5% in the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider's stock valued at $213,000 after buying an additional 978 shares during the period. Finally, State of New Jersey Common Pension Fund D increased its stake in shares of Select Medical by 2.2% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider's stock valued at $1,069,000 after acquiring an additional 1,234 shares during the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
SEM has been the topic of several research analyst reports. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price on the stock in a research report on Monday, February 24th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Royal Bank of Canada decreased their price target on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. Finally, Mizuho initiated coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $26.00.
Read Our Latest Report on Select Medical
Insider Activity at Select Medical
In other news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the stock in a transaction that occurred on Monday, May 5th. The stock was acquired at an average cost of $15.02 per share, with a total value of $315,420.00. Following the acquisition, the director now owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the business's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the transaction, the chief executive officer now owns 714,516 shares in the company, valued at $12,861,288. This represents a 23.95% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.60% of the company's stock.
Select Medical Trading Up 0.0%
SEM traded up $0.00 on Friday, reaching $15.23. 195,065 shares of the company's stock were exchanged, compared to its average volume of 1,068,561. Select Medical Holdings Co. has a twelve month low of $14.03 and a twelve month high of $40.98. The company's 50 day moving average is $16.35 and its 200-day moving average is $20.70. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $1.96 billion, a price-to-earnings ratio of 9.23, a PEG ratio of 0.64 and a beta of 1.40.
Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Select Medical's revenue was down 24.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.75 EPS. Equities analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.
Select Medical Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be paid a $0.0625 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.64%. Select Medical's dividend payout ratio (DPR) is currently 18.66%.
Select Medical declared that its Board of Directors has approved a share repurchase plan on Thursday, May 1st that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its stock is undervalued.
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report